Syqe Medical signed an agreement with the Israeli Ministry of Defense to supply the SyqeAir Inhaler and cartridges to all veterans prescribed medical cannabis by inhalation through the company's platform. This agreement allows veterans treated with medical cannabis using the SyqeAir Inhaler and cartridges to obtain them directly in the same way they access pharmaceutical drugs.
The SyqeAir Inhaler is a device that allows patients to accurately manage their medical cannabis treatment. It is composed of a patented, metered-dose system that controls the amount of cannabis delivered to the patient with each inhalation. This allows for precise dosing and a high level of patient control over their treatment. The SyqeAir Inhaler is CE (European standard) and MDL (Health Canada) approved and clinically validated by 3 clinical trials and real-world evidence publications, demonstrating its safety and efficacy.
The inhaler is designed for home use as well as a hospital setting. The pre-loaded cartridge contains 60 uniform doses of raw cannabis flowers grown by the Dutch company Bedrocan. From the moment the cartridge is inserted into the inhaler, the inhaler is ready for immediate use without any prior preparations or the need to handle the cannabis directly so that patients can take their treatment discreetly and as part of their daily routine like any other medication.